Completed NA INTERVENTIONAL 2-arm NCT04762043

MyoVoice to Restore Natural, Hands-free Communication to Individuals With Vocal Impairments

EMG Voice Restoration

Sponsor: Altec Inc.

Conditions Communication Aids for Disabled Rehabilitation of Speech and Language Disorders Speech Disorders Speech Intelligibility Speech Perception Speech, Alaryngeal

Interventions Experimental System: MyoVoice Reference System: Electrolarynx

Updated 7 times since 2021 Last updated: May 21, 2024 Started: Feb 12, 2021 Primary completion: Nov 8, 2023 Completion: Nov 8, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04762043, this NA trial focuses on Communication Aids for Disabled and Rehabilitation of Speech and Language Disorders and remains completed. Sponsored by Altec Inc., it has been updated 7 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Oct 2024 — Present [monthly]

Completed NA

Status: Unknown → Completed
Sep 2024 — Oct 2024 [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Apr 2024 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Apr 2022 — Apr 2024 [monthly]

Recruiting NA

▶ Show 2 earlier versions

Mar 2022 — Apr 2022 [monthly]

Recruiting NA
Mar 2021 — Mar 2022 [monthly]

Recruiting NA

First recorded

Feb 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Altec Inc.

Data source: Altec Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Natick, United States